333D posts first profit in five years & refocuses on healthcare

333D has reported revenue of USD $1,001,873 and posted its first annual profit in more than five years, outlining a strategy focused on healthcare and digital asset management for future growth.

The company confirmed a profit after tax of USD $143,777 for the 2025 financial year, compared with previous losses, and positive operating cashflow of USD $70,681, reversing an outflow of USD $506,606 in the previous year.

In addition to the improved financial performance, 333D's board has allocated USD $1 million to further investment in its platform as it moves into the next financial year with a focus on both organic expansion and potential acquisitions.

Financial turnaround

John Conidi, Chief Executive Officer and Managing Director, described the year as a clear turning point for the business and emphasised the company's improved position.

"Our turnaround is clear - from loss to profit in a single year," Mr Conidi said.

He outlined the direct impact of the new business model on profitability, stating:

"We've built a platform that is proven, profitable and ready to scale. Every new client we bring on flows directly into higher profits, stronger cashflow and greater shareholder value."

Healthcare at core

Healthcare remains central to 333D's strategic ambitions. The company said it will target both organic and acquisition-led growth initiatives, with preventive medicine and AI-enabled innovations cited as key areas of opportunity.

"Our focus now is on building scale and entering new markets," Mr Conidi said. "We see enormous opportunity in healthcare. Preventative medicine, full-body scanning and personalised data - especially as they converge with AI - are the types of next-level innovations we aim to lead."

333D has noted emerging industry interest from both Australian and international observers, and the company believes it is well placed to expand into areas aligned with growing global healthcare and technology trends.

Treasury and digital assets

The company has received attention for its Bitcoin treasury policy but clarified this remains a secondary aspect of operations, managed under a strict governance framework. Up to 50% of surplus cash may be allocated to Bitcoin, while healthcare and digital asset management are identified as core business lines.

"Our business isn't crypto – it's healthcare and digital asset management," Mr Conidi said. "But our treasury settings ensure surplus cash works harder for shareholders in a disciplined, well-managed way."

Prepared for expansion

Company representatives stated that 333D is entering the 2026 financial year with what they described as a profitable base, positive cash generation, enhanced investment in core capabilities and a sharpened focus on market opportunities at the convergence of healthcare, digital assets and artificial intelligence.